节点文献

安络化纤丸对急慢性肝损伤的保护作用

Protective Effect of Anluohuaxian Capsule Against the Acute and Chronic Liver Damage in Animals

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张岫美张斌魏欣冰

【Author】 Zhang Xiumei, Zhang Bin, Wei Xinbing (Dept. of Pharmacology, Shandong Medical University Jinan 250012)

【机构】 山东医科大学基础医学院药理学教研室!济南250012

【摘要】 试验证明,安络化纤丸对四氯化碳(CCl)、D-胺基半乳糖(D-Gal)引起的小鼠和大鼠急性肝损伤有明显的保护作用,能够降低血清转氨酶,减少肝细胞的变性、坏死;对CCl诱发的实验性肝硬化(肝纤维化)动物模型,能够降低血清转氨酶,升高总蛋白、白蛋白及A/G比值,降低血清唾液酸和肝组织羟脯氨酸水平,对肝细胞变性、坏死、纤维化形成乃至肝硬化均有明显的治疗作用。

【Abstract】 Anluohuaxian Capsule had a remarkable protective effects against the actue and chronic liver damage induced by CCl4 and D-galactosamine. Anluohuaxian Capsule inhibited the increase of serum aminotransferase (SGOT, SGPT). Histological lesion of liver were less severe than those of hepatic injure control. Anluohuaxian Capsule, moreover, increased the content of serum total protein (TP), albumin (ALB), and A/G ratio also in experimental liver fibrosis model induced by CCl4. Anluohuaxian Caspule still decreased serum salivary acid level and liver hydroxy-proline (Hyp) level whose content was important index of measuring liver fibrosis. It suggested that Anluohuaxian Capsule protect liver against damage induced by CCl4 and D-Gal.

  • 【文献出处】 中国生化药物杂志 ,CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS , 编辑部邮箱 ,1999年01期
  • 【分类号】R285
  • 【被引频次】44
  • 【下载频次】122
节点文献中: 

本文链接的文献网络图示:

本文的引文网络